Suppr超能文献

在对同种异体反应性CD4 T细胞进行“清除”后,跨越主要组织相容性复合体(MHC)错配的心脏同种异体移植物长期存活。

Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.

作者信息

Hu Min, Watson Debbie, Zhang Geoff Y, Graf Nicole, Wang Yuan M, Sartor Mary, Howden Brian, Fletcher Jeffrey, Alexander Stephen I

机构信息

Centre for Kidney Research and Department of Pathology, the Children's Hospital at Westmead, University of Sydney, NSW, Australia.

出版信息

J Immunol. 2008 May 15;180(10):6593-603. doi: 10.4049/jimmunol.180.10.6593.

Abstract

Specific tolerance to allografts has been achieved by a variety of means. We have previously shown that ex vivo removal of dividing CD4(+) T cells from an MLR or "pruning" delays skin allograft rejection. We tested pruning of alloreactive T cells as a strategy for retaining a broad T cell repertoire while removing alloreactive T cells in a model of cardiac allograft transplant. Using CFSE staining of responder BALB/c cells with stimulator C57BL/6 cells in an MLR, SCID mice were reconstituted with either dividing (D) or nondividing (ND) CD4(+) T cells derived from an MLR and then challenged with heterotopic cardiac allografts. Mice reconstituted with D CD4(+) T cells rejected cardiac allografts from the stimulator strain with a median survival time (MST) of 29 days, while mice reconstituted with ND CD4(+) T cells maintained allografts from the stimulator strain (MST of >100 days) while rejecting third-party allografts (B10.BR) (MST = 11 days). ELISPOT assays demonstrate donor-specific hyporesponsiveness of the ND CD4(+) T cells. TCR beta-chain V region (TRBV) repertoire analysis demonstrates clonal expansion within both rejecting D cardiac allografts and ND cardiac allografts surviving for the long-term. Histology showed greater allograft infiltration by the D CD4(+) T cells. The surviving ND cardiac allografts demonstrated reduced cellular infiltration and reduced incidence of allograft vasculopathy, but with the development of chronic fibrosis. Thus, pruning of alloreactive T cells allows long-term-specific cardiac allograft survival while retaining the ability to reject third-party allografts.

摘要

通过多种方法已实现对同种异体移植物的特异性耐受。我们之前已经表明,在混合淋巴细胞反应(MLR)中体外去除增殖的CD4(+) T细胞或“修剪”可延迟皮肤同种异体移植排斥反应。我们在心脏同种异体移植模型中测试了修剪同种异体反应性T细胞这一策略,以在去除同种异体反应性T细胞的同时保留广泛的T细胞库。在MLR中用刺激细胞C57BL/6细胞对反应性BALB/c细胞进行羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)染色,将严重联合免疫缺陷(SCID)小鼠用来自MLR的增殖(D)或非增殖(ND)CD4(+) T细胞进行重建,然后用异位心脏同种异体移植物进行攻击。用D CD4(+) T细胞重建的小鼠排斥来自刺激株的心脏同种异体移植物,中位生存时间(MST)为29天,而用ND CD4(+) T细胞重建的小鼠维持来自刺激株的同种异体移植物(MST>100天),同时排斥第三方同种异体移植物(B10.BR)(MST = 11天)。酶联免疫斑点(ELISPOT)分析证明ND CD4(+) T细胞具有供体特异性低反应性。T细胞受体β链V区(TRBV)库分析证明在排斥的D心脏同种异体移植物和长期存活的ND心脏同种异体移植物中均有克隆扩增。组织学显示D CD4(+) T细胞对同种异体移植物的浸润更多

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验